Organicell Regenerative Medicine, Inc. Accepts the Resignation of Mr. Matthew Sinnreich as President of the Company and as A Member of the Company’S Board of Directors

On November 29, 2022, Organicell’s Board of Directors (“Board”) agreed to accept the resignation of Mr. Matthew Sinnreich, who was previously serving as the Acting Chief Executive Officer and President of the Company and as a member of the Company’s Board of Directors.